Lung cancer - non-small cell and Dilatation ventricular

Summary:

Dilatation ventricular is found among people with Lung cancer - non-small cell, especially for people who are male, 60+ old.

The study analyzes which people have Dilatation ventricular with Lung cancer - non-small cell. It is created by eHealthMe based on reports of 8 people who have Lung cancer - non-small cell from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

8 people who have Lung Cancer - Non-Small Cell and Dilatation Ventricular are studied.


What is Lung cancer - non-small cell?

Lung cancer - non-small cell (lung cancer) is found to be associated with 760 drugs and 471 conditions by eHealthMe.

What is Dilatation ventricular?

Dilatation ventricular is found to be associated with 1,123 drugs and 662 conditions by eHealthMe.

Number of Dilatation ventricular in Lung cancer - non-small cell reports submitted per year:

Would you have Dilatation ventricular when you have Lung cancer - non-small cell?

Gender of people who have Lung Cancer - Non-Small Cell and experienced Dilatation Ventricular *:

  • female: 12.5 %
  • male: 87.5 %

Age of people who have Lung Cancer - Non-Small Cell and experienced Dilatation Ventricular *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 33.33 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 66.67 %

Common co-existing conditions for these people *:

  1. Type 2 Diabetes: 1 person, 12.50%
  2. High Blood Pressure: 1 person, 12.50%
  3. High Blood Cholesterol: 1 person, 12.50%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 12.50%
  5. Diarrhea: 1 person, 12.50%
  6. Diabetes: 1 person, 12.50%
  7. Depression: 1 person, 12.50%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 12.50%
  9. Back Pain: 1 person, 12.50%

Common drugs taken by these people *:

  1. Taxol: 4 people, 50.00%
  2. Carboplatin: 3 people, 37.50%
  3. Carvedilol: 2 people, 25.00%
  4. Metformin: 1 person, 12.50%
  5. Coumadin: 1 person, 12.50%
  6. Diovan: 1 person, 12.50%
  7. Folic Acid: 1 person, 12.50%
  8. Gemcitabine: 1 person, 12.50%
  9. Lasix: 1 person, 12.50%
  10. Lovastatin: 1 person, 12.50%

Common symptoms for these people *:

  1. Ejection Fraction Decreased (systolic heart failure): 5 people, 62.50%
  2. White Blood Cell Count Decreased: 4 people, 50.00%
  3. Productive Cough: 4 people, 50.00%
  4. Dizziness: 4 people, 50.00%
  5. Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 4 people, 50.00%
  6. Oxygen Saturation Decreased: 4 people, 50.00%
  7. Breathing Difficulty: 4 people, 50.00%
  8. Haemoglobin Decreased: 4 people, 50.00%
  9. Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 4 people, 50.00%
  10. Weakness: 2 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Dilatation ventricular?

Check whether Dilatation ventricular is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Dilatation ventricular:

Common drugs associated with Dilatation ventricular:

All the drugs that are associated with Dilatation ventricular:

Common conditions associated with Dilatation ventricular:

All the conditions that are associated with Dilatation ventricular:

How the study uses the data?

The study is based on Dilatation ventricular and Lung cancer - non-small cell, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: